Chengjun Ban

540 total citations
26 papers, 365 citations indexed

About

Chengjun Ban is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Chengjun Ban has authored 26 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 5 papers in Physiology and 4 papers in Surgery. Recurrent topics in Chengjun Ban's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers), Sarcoidosis and Beryllium Toxicity Research (5 papers) and Pulmonary Hypertension Research and Treatments (5 papers). Chengjun Ban is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers), Sarcoidosis and Beryllium Toxicity Research (5 papers) and Pulmonary Hypertension Research and Treatments (5 papers). Chengjun Ban collaborates with scholars based in China, Japan and United States. Chengjun Ban's co-authors include Huaping Dai, Chen Wang, Qiao Ye, Shunzo Taii, Akira Ohara, Min Zhu, Bing Sun, Yanhong Ren, Zheng Wang and Hangyong He and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Journal of Ethnopharmacology.

In The Last Decade

Chengjun Ban

25 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengjun Ban China 11 170 93 59 56 55 26 365
Eitan Halper‐Stromberg United States 10 124 0.7× 56 0.6× 50 0.8× 156 2.8× 112 2.0× 18 488
Janet Sutherland United Kingdom 15 38 0.2× 68 0.7× 62 1.1× 30 0.5× 184 3.3× 24 637
T Yagisawa Japan 12 52 0.3× 137 1.5× 19 0.3× 33 0.6× 46 0.8× 51 388
So‐Yong Kwon South Korea 6 23 0.1× 57 0.6× 17 0.3× 32 0.6× 46 0.8× 26 284
Haofeng Xiong China 11 75 0.4× 111 1.2× 11 0.2× 96 1.7× 143 2.6× 41 448
Christie L. Boils United States 8 83 0.5× 66 0.7× 31 0.5× 27 0.5× 26 0.5× 11 289
Nathalie Fouchard France 9 27 0.2× 252 2.7× 21 0.4× 145 2.6× 84 1.5× 15 1.1k
Yoshiko Tsuchihashi Japan 9 438 2.6× 93 1.0× 18 0.3× 20 0.4× 88 1.6× 33 611
Hélder Novais Bastos Portugal 14 319 1.9× 80 0.9× 34 0.6× 80 1.4× 20 0.4× 64 535
Yukikazu Awaya Japan 7 246 1.4× 110 1.2× 4 0.1× 37 0.7× 29 0.5× 29 418

Countries citing papers authored by Chengjun Ban

Since Specialization
Citations

This map shows the geographic impact of Chengjun Ban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengjun Ban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengjun Ban more than expected).

Fields of papers citing papers by Chengjun Ban

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengjun Ban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengjun Ban. The network helps show where Chengjun Ban may publish in the future.

Co-authorship network of co-authors of Chengjun Ban

This figure shows the co-authorship network connecting the top 25 collaborators of Chengjun Ban. A scholar is included among the top collaborators of Chengjun Ban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengjun Ban. Chengjun Ban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cheng, Miao, Yanan Zhang, Jun Yan, et al.. (2023). Inhibiting virus replication and excessive inflammatory response: Mechanism of combined prescription of Ma-Xing-Shi-Gan decoction and Xiao-Chai-Hu decoction against influenza virus. Journal of Ethnopharmacology. 313. 116481–116481. 15 indexed citations
3.
Chang-an, LI, et al.. (2022). Double tracheal stents reduce side effects of progression of malignant tracheoesophageal fistula treated with immunotherapy: A case report. World Journal of Clinical Cases. 10(11). 3527–3532. 1 indexed citations
4.
5.
Li, Xianping, Mingzhe Wang, Chang Liu, et al.. (2022). Qingfeiyin Decoction Inhibits H1N1 Virus Infection via Modulation of Gut Microbiota and Inflammatory Pathways in a Murine Model. Frontiers in Pharmacology. 13. 874068–874068. 8 indexed citations
6.
Ren, Yanhong, Jing Geng, Xuan He, et al.. (2020). Idiopathic Pulmonary Fibrosis Registry China study (PORTRAY): protocol for a prospective, multicentre registry study. BMJ Open. 10(11). e036809–e036809. 13 indexed citations
7.
Li, Deying, et al.. (2020). Adult-onset Still’s disease successfully treated with Chinese herbal medicine: A case report with 15-month follow-up. Journal of Integrative Medicine. 18(6). 530–534. 3 indexed citations
8.
Wang, Zheng, Qizhe Cai, Chengjun Ban, et al.. (2018). Improved heart hemodynamics after draining large-volume pleural effusion: a prospective cohort study. BMC Pulmonary Medicine. 18(1). 62–62. 7 indexed citations
9.
Zhu, Min, Jing Geng, Chengjun Ban, et al.. (2017). Incidence and radiologic‐pathological features of lung cancer in idiopathic pulmonary fibrosis. The Clinical Respiratory Journal. 12(4). 1700–1705. 25 indexed citations
10.
Ban, Chengjun, Huan‐Zhong Shi, & Yuhui Zhang. (2017). Improvement of Malignant Pleural Mesothelioma Prognosis. Chinese Medical Journal. 130(1). 1–3. 2 indexed citations
11.
Ban, Chengjun, et al.. (2017). [Clinical features of acute diffuse pulmonary exudative disorders].. PubMed. 97(44). 3445–3449. 4 indexed citations
12.
Yan, Wei, Liying Peng, Chengjun Ban, et al.. (2015). Incidence and Clinical Characteristics of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis. Chinese Medical Journal. 128(7). 896–901. 11 indexed citations
13.
Sun, Bing, Hangyong He, Zheng Wang, et al.. (2014). Emergent severe acute respiratory distress syndrome caused by adenovirus type 55 in immunocompetent adults in 2013: a prospective observational study. Critical Care. 18(4). 456–456. 64 indexed citations
14.
Cai, Miaotian, Min Zhu, Chengjun Ban, et al.. (2014). Clinical features and outcomes of 210 patients with idiopathic pulmonary fibrosis. Chinese Medical Journal. 127(10). 1868–1873. 24 indexed citations
15.
Tang, Xiao, Hangyong He, Bing Sun, et al.. (2014). ARDS associated with pneumonia caused by avian influenza A H7N9 virus treated with extracorporeal membrane oxygenation. The Clinical Respiratory Journal. 9(3). 380–384. 13 indexed citations
16.
Dai, Huaping, Jianqun Liu, Lirong Liang, et al.. (2014). Increased lung cancer risk in patients with interstitial lung disease and elevated CEA and CA125 serum tumour markers. Respirology. 19(5). 707–713. 39 indexed citations
17.
He, Xuan, Huaping Dai, Bing Sun, et al.. (2013). Pneumonia relevant to lung transplantation and pathogen distribution. Chinese Medical Journal. 126(17). 3209–3214. 10 indexed citations
18.
Takenaka, Tadashi, Ken Yoshida, Seiji Tachiiri, et al.. (2012). Comparison of dose-volume analysis between standard Manchester plan and magnetic resonance image-based plan of intracavitary brachytherapy for uterine cervical cancer. Journal of Radiation Research. 53(5). 791–797. 9 indexed citations
19.
Liu, Long, Huaping Dai, Bai Xiao, et al.. (2009). [Association of ENA-78, IP-10 and VEGF gene polymorphism with idiopathic pulmonary fibrosis].. PubMed. 89(38). 2690–4. 9 indexed citations
20.
Ohara, Akira, et al.. (1987). Functional Differentiation in Steroidogenesis of Two Types of Luteal Cells Isolated from Mature Human Corpora Lutea of Menstrual Cycle*. The Journal of Clinical Endocrinology & Metabolism. 65(6). 1192–1200. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eitan Halper‐Stromberg Breakdown of academic impact, for papers by Janet Sutherland Breakdown of academic impact, for papers by T Yagisawa Breakdown of academic impact, for papers by So‐Yong Kwon Breakdown of academic impact, for papers by Haofeng Xiong Breakdown of academic impact, for papers by Christie L. Boils Breakdown of academic impact, for papers by Nathalie Fouchard Breakdown of academic impact, for papers by Yoshiko Tsuchihashi Breakdown of academic impact, for papers by Hélder Novais Bastos Breakdown of academic impact, for papers by Yukikazu Awaya
Rankless by CCL
2026